Recombinant VEGF (Bevacizumab Biosimilar) anticorps

N° du produit ABIN5668150

Cet anticorps anti-VEGF (Bevacizumab Biosimilar) est un anticorps Human Monoclonal détectant VEGF (Bevacizumab Biosimilar) dans FACS, ELISA, BR, IP et WB. Adapté pour Humain.

Aperçu rapide pour Recombinant VEGF (Bevacizumab Biosimilar) anticorps (ABIN5668150)

Antigène: VEGF (Bevacizumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Human

Clonalité: Monoclonal

Conjugué: Cet anticorp VEGF (Bevacizumab Biosimilar) est non-conjugé

Application: Flow Cytometry (FACS), ELISA, Blocking Reagent (BR), Immunoprecipitation (IP), Western Blotting (WB)

Détail du produit anti-VEGF (Bevacizumab Biosimilar) anticorps

Fonction: Anti-VEGF [Bevacizumab], Human IgG1, kappa

Specificité: This antibody binds native and reduced human VEGF (isoform 165).

Attributs du produit:

Original Species of Ab: Human

Original Format of Ab: IgG1

Purification: Protein A affinity purified

Pureté: > 98 % as determined by SDS-PAGE

niveau d'endotoxine: Endotoxin is < 1.0 EU/mg as determined by the LAL method

Immunogène: Recombinant human VEGF.

Isotype: IgG1 kappa

Information d'application

Indications d'application: This is a research-grade biosimilar against VEGF. VEGF is a growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. It induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels.

Commentaires:

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

Restrictions: For Research Use only

Stockage

Concentration: 1 mg/mL

Buffer: PBS with 0.02 % Proclin 300.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.

Détails sur VEGF (Bevacizumab Biosimilar)

Antigène: VEGF (Bevacizumab Biosimilar)

Sujet: Ascular Endothelial Growth Factor, VEGF-A, VEGFA, Vascular Permeability Factor, VPF

UniProt: P15692